Journal of Hepato-Biliary-Pancreatic Surgery

, Volume 4, Issue 4, pp 359–364 | Cite as

Efficacy of preoperative portal vein embolization prior to major hepatectomy for patients with impaired liver function: A retrospective study

  • Shoji Kubo
  • Hiroaki Kinoshita
  • Kazuhiro Hirohashi
  • Hiromu Tanaka
  • Tadashi Tsukamoto
  • Taichi Shuto
  • Yoshihiko Morimoto
  • Akishige Kanazawa
  • Shinichi Mikami
  • Chikaharu Sakata
Topics

Abstract

Hepatocellular carcinoma (HCC) is often associated with chronic liver disease, such as hepatitis or cirrhosis, and this association may limit the use of surgery as a therapy, and if surgery is pursued, may give rise to postoperative hepatic failure. We evaluated the outcome in patients with HCC given preoperative portal vein embolization (PVE) before they underwent major hepatectomy. After PVE, portal pressure increased significantly. Two weeks after PVE, both the volume of the non-embolized lobe and the 15-min indocyamine green retention rate (ICG R15) were significantly increased. The prognostic score, calculated on the basis of age, ICG R15, and the resection rate, was significantly decreased. The operative mortality rate was significantly lower in patients who underwent PVE before surgery than in patients who did not receive PVE. The cumulative survival rate of the PVE patients, even those with cirrhosis of the liver, was significantly higher. Prior PVE appears to allow more extensive major hepatectomy and to lessen the risk of this invasive surgery. However, patients in whom the portal pressure immediately after PVE was more than 30cm H2O and/or whose prognostic score exceeded 50 points developed postoperative hepatic failure. These features should be kept in mind when it is decided whether surgery is indicated. Nevertheless, preoperative PVE appears to be a beneficial procedure for patients undergoing major hepatectomy, particularly those with chronic liver disease.

Key words

portal vein embolization hepatocellular carcinoma liver resection portal pressure liver cirrhosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan: Clinicopathologic features and results of surgical tretment. Ann Surg 21:277–287.Google Scholar
  2. 2.
    Kinoshita H., Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10:803–808.PubMedCrossRefGoogle Scholar
  3. 3.
    Kubo S, Kinoshita H, Hirohashi K, Iwasa R, Fujio N, Ikeda K (1993) Preoperative portal vein embolization for hepatocellular carcinoma with portal thrombi. In: Takahashi T (ed) Recent advances in management of digestive cancers. Springer, Berlin Heidelberg New York Tokyo, pp 654–656Google Scholar
  4. 4.
    Kubo S, Kinoshita H, Hirohashi K, Iwasa R, Fujio N, Nakamura H (1993) Combination of hepatic arterial infusion chemotherapy and portal vein occulusion for unresectable hepatocellular carcinoma. In: Takahashi T (ed) Recent advances in management of digestive cancers. Springer, Berlin Heidelberg New York Tokyo, pp 678–680Google Scholar
  5. 5.
    Kubo S, Matsui-Yuasa I, Otani S, Morisawa S, Kinoshita H, Sakai K (1986) Effect of portal branch ligation on polyamine metabolism in rat liver. Life Sci 38:1835–1840PubMedCrossRefGoogle Scholar
  6. 6.
    Kinoshita H, Sakai K, Iwasa R, Hirohashi K, Kubo S, Fujio N, Lee KC (1988) Results of preoperative portal vein embolization for hepatocellular carcinoma. Osaka City Med J 13:211–218Google Scholar
  7. 7.
    Fujio N, Sakai K, Kinoshita H, Hirohashi K, Kubo S, Iwasa R, Lee KC (1989) Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver. World J Surg 13:211–218PubMedCrossRefGoogle Scholar
  8. 8.
    Kinoshita H, Hirohashi K, Kubo S (1992) Preoperative portal vein embolization for hepatocellular carcinoma. In: Tobe R, Kameda H, Okudaira M, Ohto M, Endo Y, Mito M, Okamoto E, Tanikawa K, Kojiro M (eds) Primary liver cancer in Japan. Springer, Berlin, pp 283–290Google Scholar
  9. 9.
    Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R (1993) Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 17:109–115PubMedCrossRefGoogle Scholar
  10. 10.
    Tanaka H, Kinoshita H, Hiroshi K, Kubo S, Lee KC (1994) Increased safety by two-stage hepatectomy with preoperative portal vein embolization in rats. J Surg Res 57:687–692PubMedCrossRefGoogle Scholar
  11. 11.
    Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T. Gunven P, Yamazaki S, Hasegawa H, Ozaki H (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 107:521–527PubMedGoogle Scholar
  12. 12.
    Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Kutsuna Y, Hayakawa N, Yamamoto H (1995) Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 117:677–681PubMedCrossRefGoogle Scholar
  13. 13.
    Kubo S, Kinoshita H, Hirohashi K (1994) Preoperative portal vein embolization with fibrin sealant for hepatocellular carcinoma. In: Schlag G, Waclawiczek H-W, Daum R (eds) Fibrin sealing in surgical and nonsurgical fields. 2. General and abdominal surgery. Pediatric surgery. Springer, Berlin, pp 18–26Google Scholar
  14. 14.
    Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K (1984) Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 95:586–592.PubMedGoogle Scholar
  15. 15.
    Suenaga M, Nakao A, Harada A, Nonami T, Okada Y, Sugiura H, Uehara S, Takagi H (1992) Hepatic resection for hepatocellular carcinoma. World J Surg 16:97–105PubMedCrossRefGoogle Scholar
  16. 16.
    Nagasue N, Kohno H, Chang Y-C, Taniura H, Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T, Yukaya H (1993) Liver resection for hepatocellular carcinoma: Results of 229 consective patients during 11 years. Ann Surg 217:375–384PubMedGoogle Scholar
  17. 17.
    Carlo VD, Ferrari G, Castoldi R, Nadalin S, Marenghi C, Molteni B, Taccagni G, Castrucci M (1995) Surgical treatment and prognostic variables of hepatocellular carcinoma in 122 cirrhotics. Hepatogastroenterology 42:222–229PubMedGoogle Scholar
  18. 18.
    Lai ECS, Fan ST, Lo C-M, Chu K-M, Liu C-L, Wong J (1995) Hepatic resection for hepatocellular carcinoma. Ann Surg 221:291–298PubMedGoogle Scholar
  19. 19.
    Noguchi T, Imai T, Mizumoto R (1990) Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients. Hepatogastroenterology 37:165–171PubMedGoogle Scholar
  20. 20.
    Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T (1987) Human liver regeneration after major hepatic resection: A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 206:30–39PubMedGoogle Scholar
  21. 21.
    Ito Y, Hayashi H, Taira M, Tatibana M, Tabata Y, Isono K (1991) Deptession of liver-specific gene expression in regenerating rat liver: A putative cause for liver dysfunction after hepatectomy. J Surg Res 51:143–147PubMedCrossRefGoogle Scholar
  22. 22.
    Campbell KA, Wu Y, Chacko VP, Sitzmann JV (1990) In vivo31P NMR spectroscopic changes during liver regeneration. J Surg Res 49:244–247PubMedCrossRefGoogle Scholar
  23. 23.
    Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization: An appraisal by biliary indocyanine green exretion. Ann Surg 223:77–83PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • Shoji Kubo
    • 1
  • Hiroaki Kinoshita
    • 1
  • Kazuhiro Hirohashi
    • 1
  • Hiromu Tanaka
    • 1
  • Tadashi Tsukamoto
    • 1
  • Taichi Shuto
    • 1
  • Yoshihiko Morimoto
    • 1
  • Akishige Kanazawa
    • 1
  • Shinichi Mikami
    • 1
  • Chikaharu Sakata
    • 1
  1. 1.Second Department of SurgeryOsaka City University Medical SchoolOsakaJapan

Personalised recommendations